AI, Biomarkers and the Future of Longevity Medicine, with Elio Verhoef, Co-Founder of LongevAI

In this episode, Daphna sits down with Elio, co-founder of LongevAI, a platform using artificial intelligence to help longevity clinics analyse biomarker data, streamline documentation, and build personalised client plans.

With a background in computer science and a lifelong passion for health optimisation, Elio offers a grounded, honest perspective on what AI in longevity medicine can do today, and where the limits still lie.

______________

What We Cover

• How LongevAI was founded and what problem it solves for longevity clinics

• What it means to automate clinical documentation without removing the clinician from the process

• How AI interprets biomarker data, and why speed and accuracy both play a role

• The hallucination problem: what it is, why it happens, and how it is being managed

• Data privacy, GDPR compliance, and anonymisation in clinical AI tools

• The importance of human oversight, why the clinician must always approve before anything reaches the client

• How AI and clinicians can learn from each other in a feedback loop

• Wearable integration and the role of continuous vs snapshot data

• Where AI in longevity is heading in two to five years, including gene therapy modelling and whole-cell simulation

• Why younger people are beginning to engage with longevity, and what still holds them back

About the Guest

Elio is the co-founder of LongevAI, a software platform built for longevity clinics. He holds a double bachelor's degree in Computer Science and Information Science, and has been focused on health optimisation and AI since his teens. He co-founded LongevAI in December 2024 alongside Cosmina Druica, whom he met through a longevity meetup community in the Netherlands.

🔗 longevai.com

Enjoyed this episode? Please subscribe, leave a review on Apple Podcasts or Spotify, and share with anyone curious about the future of longevity medicine.

Beyond Longevity is hosted by Daphna Stern · beyond-longevity.co.uk

In this episode:

00:00 Welcome and Guest Intro

01:52 Elio Background and Origins

04:01 What Lev AI Does

05:06 Automating Clinic Workflows

07:52 Speed vs Accuracy

11:45 Oversight and Patient Trust

12:57 Privacy and GDPR Security

13:56 How the Model Improves

15:06 Limits Data and Hallucinations

21:37 Training and Integrations

23:45 Personal Biomarker Walkthrough

28:34 Explaining LLMs to non-tech people

33:38 Future of AI and Longevity

35:32 Young People and Longevity

39:56 Rapid Fire Questions

43:45 Wrap Up and Key Takeaways

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(31)

How Much Control Do We Really Have Over Our Health? Spermidine, Autophagy and Patient Empowerment

At 39, Leslie Kenny was diagnosed with rheumatoid arthritis and lupus and says she was told she had around five years to live. More than two decades later, she is in long-term remission and has turned...

9 Elo 59min

The Hardest Problem in Longevity Is Human Behaviour with Dr Gil Blander, Founder of InsideTracker

Nearly two decades ago, Dr Gil Blander was trying to convince investors of an idea that, at the time, sounded radical: blood biomarkers should not only be used to diagnose disease, but to help healthy...

2 Elo 48min

Longevity Medicine Beyond ‘Failure-Based’ Healthcare with Dr Peter Scriven

In this episode of Beyond Longevity, Daphna speaks with Dr Peter Scriven, Co-Founder and Clinical & Scientific Director of LONGEVITY, about what longevity medicine should actually look like: moving fr...

26 Heinä 1h 2min

Longevity at HLTH Why Healthy Ageing Is Finally Going Mainstream

In this episode of Beyond Longevity, Daphna speaks with Jody Tropeano Greene, Head of Content at HLTH, and Alexa Mikhail, Senior Content Lead at HLTH US, about how HLTH identifies the healthcare topic...

19 Heinä 52min

From Blockbuster Medicine to Extending Healthspan with Sundeep Dugar PhD

On Beyond Longevity, host Daphna speaks with Dr Sundeep Dugar, PhD, co-founder of BlueOakNx and the scientists behind the blockbuster cholesterol medicines Zetia (ezetimibe) and Vytorin. He explains h...

12 Heinä 59min

Robert Gielow on Longevity Products, Pharmacy Access and Consumer Trust with a focus on the German speaking market

Daphna sat down with Robert Gielow, founder of Mentry Pharma, to discuss what it really takes for foreign supplement and longevity companies to enter the pharmacy markets of Germany, Austria and Switz...

5 Heinä 1h

AI, Ageing And The Question Of Trust with Dr Filippo Dall'Armellina

Biology is undergoing one of the biggest transformations in its history. AI is helping researchers analyse enormous datasets, predict protein structures, identify drug targets, and accelerate scientif...

28 Kesä 57min

Kyle Holbert on Heavy Metals, Missed Diagnoses and Making Longevity Medicine More Accessible

Beyond Longevity interviews Kyle Holbert, COO and co-founder of Longevity Centres of America, about how unexplained fatigue, brain fog, depression, anxiety, joint pain and gut issues derailed his heal...

21 Kesä 57min